Kidney Research and Clinical Practice

Kidney Research and Clinical Practice(英文缩写 KIDNEY RES CLIN PRAC),ISSN 2211-9132,eISSN 2211-9140 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

Kidney Research and Clinical Practice 最新收录文献

※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。

1. Advances in the study of sodium-glucose cotransporter 2 inhibitors for peritoneal dialysis.
   Juan Chen, Jie Yang, Bengang Huo, Mingyu Cai, Wenjiang Gong, Qingli Cai
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42745946

   Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are a novel class of hypoglycemic agents widely used in clinical practice in recent years. Recent studies have revealed that sodium-glucose cotransp…

   查看详情 DOI
2. Histamine H1 receptor as a potential prophylactic target for COVID-19-induced acute kidney injury during pregnancy.
   Itsuro Kazama, Kurumi Sugawara, Hikaru Honda, Kinari Kawamura, Kanata Segawa
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42745945
   查看详情 DOI
3. Smart medical technologies in peritoneal dialysis: current applications and future perspectives.
   Dan Li, Ibtasam Wajid, Hao Liu, Siqi Li, Qin Wang
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42702393

   With the global rise in end-stage kidney disease cases, peritoneal dialysis (PD) has become a critical treatment modality for maintaining patients' quality of life. This narrative review aims to summa…

   查看详情 DOI
4. Facility-level comorbidity burden and cardiovascular outcome in patients undergoing hemodialysis.
   Hyo Jeong Kim, Seok-Jae Heo, Jung Tak Park, Ga Young Heo, Kyung Won Kim, Yong Uk Kwon
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42736596

   The impact of facility-level comorbidity burden on the prognosis of hemodialysis patients remains unclear. This study aimed to investigate the association between facility-level comorbidity burden and…

   查看详情 DOI
5. Denosumab for kidney transplant recipients: clinical value and unresolved questions.
   Hye-Sun Park
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42736595
   查看详情 DOI
6. Comprehensive review of thrombotic microangiopathy: classification, genetics, and management.
   Charan Bale, Vivek Biradar, Atul Sajgure, Tushar Dighe
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42682158

   Thrombotic microangiopathy (TMA) comprises syndromes characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ injury, most commonly affecting the kidneys and brain. Recent advan…

   查看详情 DOI
7. Incretin-based therapies in diabetic kidney disease: toward integrated cardio-kidney-metabolic disease modification. 糖尿病肾病中基于肠促胰岛素的疗法：朝向综合性心肾代谢疾病的改造
   Yaeni Kim, Eun Young Lee
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42682157

   Obesity and type 2 diabetes (T2D) are dominant drivers of chronic kidney disease (CKD) within the cardio-kidney-metabolic (CKM) syndrome. Despite advances with renin-angiotensin system inhibitors and …

   查看详情 DOI
8. Response to the letter regarding "Genetic diagnosis of hereditary kidney disease in pediatric patients through whole-exome sequencing and mitochondrial DNA analysis".
   Jiyoung Oh, Keumwha Lee, Dongju Won, Young-Mock Lee, Jae Il Shin
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42548166
   查看详情 DOI
9. Before new variants in genes associated with hematuria or proteinuria can be classified as causative, their pathogenicity must be demonstrated.
   Sounira Mehri, Josef Finsterer
   Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42521291
   查看详情 DOI
10. New strategy to regulate immunopathogenic processes of glomerulonephritis.
    Ho Jun Chin
    Kidney research and clinical practice 2026 IF: 3.50 Q1 PMID: 42415615
    查看详情 DOI